Qiagen stock last at EUR 39.470, up 1.64 percent in Xetra trading

Qiagen stock opened at EUR 38.760 and traded between EUR 38.500 and EUR 39.765. It was last at EUR 39.470, up 1.64 percent in Xetra trading, versus a EUR 38.835 reference price.

Qiagen was last at EUR 39.470 in Xetra trading at 10:49 a.m. CET on September 25, 2026, up 1.64 percent or EUR 0.635. Investing.com listed an intraday range of EUR 38.500 to EUR 39.765. Qiagen's US listing opened at USD 44.57, up 2.0 percent, according to MarketBeat.

The session on September 25, 2026 in figures

Qiagen N.V. (ISIN NL0012169213) started at EUR 38.760 in Xetra trading, based on the session data reported for September 25, 2026. The stock reached EUR 39.765 at its session high and EUR 38.500 at its session low. The last Xetra value of EUR 39.470 stood EUR 0.635 above the EUR 38.835 reference price. The session range measured EUR 1.265 from high to low.

Qiagen's last quoted level was 17.40 percent above the reported 52-week low of EUR 27.560 and 17.08 percent below the 52-week high of EUR 47.595. The stock's 350,230-share volume was below the listed three-month average of 619,290 shares. The 10:49 a.m. CET Xetra value remained an intraday level rather than an official end-of-session value.

QIAmini launch and institutional buying shape the background

Finanznachrichten reported that Qiagen launched QIAmini, an automated sample preparation system for small-batch laboratory work. The report said the system can reduce hands-on processing time by more than 80 percent versus manual preparation. MarketBeat reported that State Street increased its Qiagen holding by 4.5 percent in the second quarter. State Street owned 2,183,206 shares after buying 93,575 additional shares.

Finanznachrichten also reported that Deutsche Bank Research maintained a Buy rating on Qiagen with a EUR 47 price target ahead of third-quarter results. Analyst Jan Koch was cited in the report. Berenberg's separate September 11 recommendation was Hold with a EUR 40 target. The reported rationale cited attractive life-science markets but limited expectations for a broad sector recovery.

Qiagen trading across Xetra and New York on September 25, 2026

Qiagen's Xetra range extended from EUR 38.500 to EUR 39.765, while the last quoted level was EUR 39.470. The stock's reference price of EUR 38.835 placed the intraday gain at EUR 0.635. Qiagen's NYSE-listed shares opened at USD 44.57, up 2.0 percent, with regular US trading still underway at the stated European publication window.

The cross-listed shares gave investors two active price references in euros and dollars. The Xetra quote stood 1.64 percent above its reference price, while the US opening move was 2.0 percent. The company news and institutional filing provided dated developments alongside the session figures.